Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lindsey Rolfe currently holds 690,900 shares of CERO THERAPEUTICS HOLDINGS, INC. (CERO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lindsey Rolfe has been a net seller of CERO stock. They have purchased $0 and sold $1.3M worth of shares.
Lindsey Rolfe's most recent insider trade was on Jan 7, 2026, when they sold 690,900 shares at $0.00 per share.
Lindsey Rolfe serves as Executive at CERO THERAPEUTICS HOLDINGS, INC. (CERO). They have executed 142 insider transactions totaling $1.3M over their tenure at the company.
Lindsey Rolfe holds the position of Executive at CERO THERAPEUTICS HOLDINGS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Lindsey Rolfe has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lindsey Rolfe was on Feb 2, 2021, when they sold $78.3K worth of CLVS shares. This transaction involved 9,822 shares at $7.97 per share.
Lindsey Rolfe currently owns 690,900 shares of CERO THERAPEUTICS HOLDINGS, INC. (CERO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lindsey Rolfe's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lindsey Rolfe has 142 Form 4 filings on record as an insider at CERO THERAPEUTICS HOLDINGS, INC..
Set alerts for Lindsey Rolfe and 40,000+ other insiders.